Giphart-Gassler M - Search Results

1

Lack of genetic and epigenetic changes in meningiomas without NF2 loss.

van Tilborg AA, Morolli B, Giphart-Gassler M, de Vries A, van Geenen DA, Lurkin I, Kros JM, Zwarthoff EC. van Tilborg AA, et al. Among authors: giphart gassler m. J Pathol. 2006 Mar;208(4):564-73. doi: 10.1002/path.1909. J Pathol. 2006. PMID: 16353169

2

Intrinsic genetic instability of normal human lymphocytes and its implication for loss of heterozygosity.

de Nooij-Van Dalen AG, Morolli B, van der Keur M, van der Marel A, Lohman PH, Giphart-Gassler M. de Nooij-Van Dalen AG, et al. Genes Chromosomes Cancer. 2001 Apr;30(4):323-35. doi: 10.1002/gcc.1098. Genes Chromosomes Cancer. 2001. PMID: 11241785

3

A search for novel tumour suppressor genes for adult acute leukaemia by allelotyping at sub-telomeric chromosomal regions.

Giphart-Gassler M, De Nooij-Van Dalen A, Van Buuren-Van Seggelen V, Morolli B, Lohman P, Kluin-Nelemans H. Giphart-Gassler M, et al. Mutat Res. 1998 May 25;400(1-2):409-19. doi: 10.1016/s0027-5107(98)00022-0. Mutat Res. 1998. PMID: 9685700

4

Identification of RUNX1/AML1 as a classical tumor suppressor gene.

Silva FP, Morolli B, Storlazzi CT, Anelli L, Wessels H, Bezrookove V, Kluin-Nelemans HC, Giphart-Gassler M. Silva FP, et al. Oncogene. 2003 Jan 30;22(4):538-47. doi: 10.1038/sj.onc.1206141. Oncogene. 2003. PMID: 12555067

5

Genome wide molecular analysis of minimally differentiated acute myeloid leukemia.

Silva FP, Almeida I, Morolli B, Brouwer-Mandema G, Wessels H, Vossen R, Vrieling H, Marijt EW, Valk PJ, Kluin-Nelemans HC, Sperr WR, Ludwig WD, Giphart-Gassler M. Silva FP, et al. Among authors: giphart gassler m. Haematologica. 2009 Nov;94(11):1546-54. doi: 10.3324/haematol.2009.009324. Epub 2009 Sep 22. Haematologica. 2009. PMID: 19773259 Free PMC article.

6

ETV6 mutations and loss in AML-M0.

Silva FP, Morolli B, Storlazzi CT, Zagaria A, Impera L, Klein B, Vrieling H, Kluin-Nelemans HC, Giphart-Gassler M. Silva FP, et al. Among authors: giphart gassler m. Leukemia. 2008 Aug;22(8):1639-43. doi: 10.1038/leu.2008.34. Epub 2008 Feb 28. Leukemia. 2008. PMID: 18305557 No abstract available.

7

Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system.

Jordanova ES, Riemersma SA, Philippo K, Giphart-Gassler M, Schuuring E, Kluin PM. Jordanova ES, et al. Genes Chromosomes Cancer. 2002 Sep;35(1):38-48. doi: 10.1002/gcc.10093. Genes Chromosomes Cancer. 2002. PMID: 12203788

8

Chromosome loss with concomitant duplication and recombination both contribute most to loss of heterozygosity in vitro.

de Nooij-van Dalen AG, van Buuren-van Seggelen VH, Lohman PH, Giphart-Gassler M. de Nooij-van Dalen AG, et al. Genes Chromosomes Cancer. 1998 Jan;21(1):30-8. doi: 10.1002/(sici)1098-2264(199801)21:1<30::aid-gcc5>3.0.co;2-9. Genes Chromosomes Cancer. 1998. PMID: 9443039

9

Both the rate and spectrum of loss of heterozygosity differ between human lymphoblastoid cells derived from various donors.

de Nooij-van Dalen AG, Giphart MJ, Lohman PH, Giphart-Gassler M. de Nooij-van Dalen AG, et al. Mutat Res. 1999 Jan 25;423(1-2):1-10. doi: 10.1016/s0027-5107(98)00204-8. Mutat Res. 1999. PMID: 10029664

10

Molecular methods for the detection of mutations.

Monteiro C, Marcelino LA, Conde AR, Saraiva C, Giphart-Gassler M, De Nooij-van Dalen AG, Van Buuren-van Seggelen V, Van der Keur M, May CA, Cole J, Lehmann AR, Steinsgrimsdottir H, Beare D, Capulas E, Armour JA. Monteiro C, et al. Teratog Carcinog Mutagen. 2000;20(6):357-86. doi: 10.1002/1520-6866(2000)20:6<357::aid-tcm5>3.0.co;2-g. Teratog Carcinog Mutagen. 2000. PMID: 11074520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page